Tyra Biosciences TYRA
NASDAQ TYRA
$28.65 +3.79 (+15.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026)

Tyra Biosciences' (TYRA) quarterly Prepaid Assets came in at $11.1 million in Q1 2026, up 98.24% YoY from $5.6 million in Q1 2025, and up 18.0% on a QoQ basis from $9.4 million in Q4 2025.

Analysis

Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026) Analysis & Trends

Tyra Biosciences (TYRA) has 7 years of Prepaid Assets data on file, last reported at $11.1 million in Q1 2026.

  • Quarterly Prepaid Assets rose 98.24% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 98.24% YoY) and the FY2025 annual result came in at $9.4 million, up 56.87% from the prior year.
  • Prepaid Assets advanced to $11.1 million in Q1 2026, from $9.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $11.1 million in Q1 2026 to a low of $1.5 million in Q1 2022.
  • A 5-year average of $6.3 million and a median of $6.0 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets surged 528.32% — and 2024, when it sank 42.66%.
  • Tracing TYRA's Prepaid Assets over 5 years: stood at $6.1 million in 2022, then soared by 35.01% to $8.2 million in 2023, then declined by 26.58% to $6.0 million in 2024, then jumped by 56.87% to $9.4 million in 2025, then climbed by 18.0% to $11.1 million in 2026.
  • The last three Prepaid Assets figures came in at $11.1 million (Q1 2026), $9.4 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Tyra Biosciences 1.94 Bn 1.94 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.02 Mn
Mar 31, 2026 11.15 Mn
Dec 31, 2025 9.45 Mn
Sep 30, 2025 6.29 Mn
Jun 30, 2025 5.88 Mn
Mar 31, 2025 5.62 Mn
Dec 31, 2024 6.02 Mn
Sep 30, 2024 5.48 Mn
Jun 30, 2024 4.78 Mn
Mar 31, 2024 8.32 Mn
Dec 31, 2023 8.20 Mn
Sep 30, 2023 8.98 Mn
Jun 30, 2023 8.33 Mn
Mar 31, 2023 5.01 Mn
Dec 31, 2022 6.08 Mn
Sep 30, 2022 4.26 Mn
Jun 30, 2022 2.19 Mn
Mar 31, 2022 1.53 Mn
Dec 31, 2021 1.88 Mn
Sep 30, 2021 678,000.00